Cargando…

Lessons learned: from mentored to mentor

This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-sc...

Descripción completa

Detalles Bibliográficos
Autor principal: Heitman, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843041/
https://www.ncbi.nlm.nih.gov/pubmed/36647823
http://dx.doi.org/10.1172/JCI167444
Descripción
Sumario:This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-science researchers. In 2018, the award recognized Joseph Heitman (Figure 1), for his key contributions to our understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance and his discovery of TOR and FKBP12 as targets of the immunosuppressive chemotherapeutic drug rapamycin. Dr. Heitman has mentored numerous undergraduates, medical students, graduate students, and postdoctoral and medical fellows, many of whom have developed independent careers in medicine and basic biomedical research.